1. Home
  2. ORIC vs FRPH Comparison

ORIC vs FRPH Comparison

Compare ORIC & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • FRPH
  • Stock Information
  • Founded
  • ORIC 2014
  • FRPH 1986
  • Country
  • ORIC United States
  • FRPH United States
  • Employees
  • ORIC N/A
  • FRPH N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • FRPH Real Estate
  • Sector
  • ORIC Health Care
  • FRPH Finance
  • Exchange
  • ORIC Nasdaq
  • FRPH Nasdaq
  • Market Cap
  • ORIC 362.9M
  • FRPH 519.9M
  • IPO Year
  • ORIC 2020
  • FRPH N/A
  • Fundamental
  • Price
  • ORIC $11.10
  • FRPH $27.06
  • Analyst Decision
  • ORIC Strong Buy
  • FRPH
  • Analyst Count
  • ORIC 9
  • FRPH 0
  • Target Price
  • ORIC $18.29
  • FRPH N/A
  • AVG Volume (30 Days)
  • ORIC 964.9K
  • FRPH 49.6K
  • Earning Date
  • ORIC 08-11-2025
  • FRPH 08-06-2025
  • Dividend Yield
  • ORIC N/A
  • FRPH N/A
  • EPS Growth
  • ORIC N/A
  • FRPH 12.32
  • EPS
  • ORIC N/A
  • FRPH 0.36
  • Revenue
  • ORIC N/A
  • FRPH $31,576,000.00
  • Revenue This Year
  • ORIC N/A
  • FRPH N/A
  • Revenue Next Year
  • ORIC N/A
  • FRPH N/A
  • P/E Ratio
  • ORIC N/A
  • FRPH $75.21
  • Revenue Growth
  • ORIC N/A
  • FRPH 4.58
  • 52 Week Low
  • ORIC $3.90
  • FRPH $25.37
  • 52 Week High
  • ORIC $14.67
  • FRPH $33.00
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 66.82
  • FRPH 49.15
  • Support Level
  • ORIC $10.42
  • FRPH $26.78
  • Resistance Level
  • ORIC $11.50
  • FRPH $27.36
  • Average True Range (ATR)
  • ORIC 0.62
  • FRPH 0.60
  • MACD
  • ORIC -0.03
  • FRPH -0.02
  • Stochastic Oscillator
  • ORIC 83.30
  • FRPH 34.68

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About FRPH FRP Holdings Inc.

FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).

Share on Social Networks: